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Introduction
============

Rho-family GTPases, including Rho (A, B, and C isoforms), Rac (1, 2, and 3 isoforms), and Cdc42, regulate a number of cell functions, including gene expression, cell adhesion, and cell division ([@bib33]; [@bib1]). Earlier analyses using *Xenopus* and sand dollar eggs have shown that Rho and Cdc42 play a particularly essential role in cytokinesis ([@bib15]; [@bib19]; [@bib4]). The importance of Rho in cytokinesis has further been supported by the observations that Rho and its effectors (ROCK and citron) accumulate at the cleavage furrow ([@bib43]; [@bib20]; [@bib16]), and that cytokinesis is perturbed by the expression of dominant-negative forms of citron and ROCK ([@bib20]) or by an inhibitor to ROCK ([@bib17]). It has also been proposed that Rac and Cdc42 are involved in the cytokinesis of mammalian cells, based on the appearance of multinucleated cells among cells expressing constitutively active Rac1 or Cdc42 ([@bib5]; [@bib30]).

Rho-family GTPases are regulated by three classes of protein: guanine nucleotide exchange factors (GEFs),[\*](#fn1){ref-type="fn"} GTPase-activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs) ([@bib42]). GEF promotes exchange of GDP bound to Rho-family GTPases with GTP, and this exchange causes the Rho-family GTPases to bind to their effector proteins. The GTP-bound active Rho-family GTPases return to the GDP-bound inactive form by GTP hydrolysis, which is strongly promoted by GAP. GDI extracts GDP-bound Rho-family GTPases from membrane compartments and holds them in the cytoplasm ([@bib38]). As expected from the aforementioned role of Rho-family GTPases in cytokinesis, there has been a plethora of reports on the critical roles of these regulators in cytokinesis ([@bib39]).

Despite the accumulated knowledge on the involvement of Rho-family GTPases in many intracellular signaling events, their spatio-temporal regulation has not been assessed until recently, mostly due to the difficulty in monitoring their activities. To overcome this difficulty, in vivo probes have been developed based on the principle of fluorescence resonance energy transfer (FRET; [@bib18]; [@bib27]; [@bib13]). FRET is a nonradiative transfer of energy between two fluophores that are placed in close vicinity and in a proper relative angular orientation ([@bib47]). Variants of GFP have provided genetically encoded fluophores that serve as donor and/or acceptor in FRET ([@bib10]; [@bib23]; [@bib26]). Using these GFP variants and FRET technology, we previously developed genetically encoded probes, called Raichu, for the monitoring of activities of low mol wt GTPases in living cells ([@bib27]; [@bib13]). Here, we introduce two new Raichu probes, Raichu-RhoA and Raichu-RBD, for the monitoring of RhoA activity. Then, we use these new FRET-based probes to demonstrate that Rho-family GTPases are regulated in a manner dependent on space and time during cell division.

Results
=======

Development of Raichu-RhoA
--------------------------

As a follow-up to our previous probes for Ras-superfamily GTPases, here we developed the probes for RhoA, which generally consisted of truncated RhoA (aa 1--189), the RhoA-binding domain (RBD) of effectors, and a pair of GFP mutants, YFP and CFP ([Fig. 1](#fig1){ref-type="fig"} A). In these probes, the intramolecular binding of GTP-RhoA to the effector protein was expected to bring CFP in closer proximity to YFP, resulting in an increase in FRET from CFP to YFP. We chose mDia, Rhotekin, Rhophilin, and PKN for the RhoA effector proteins, and tested probes with either of the configurations YFP--RhoA--effector--CFP or YFP--effector--RhoA--CFP. The Rac1/Cdc42-binding domain of PAK was used as a negative control. As a typical example, the emission profile of Raichu--RhoA--1237X, which will be described later in detail, is shown in [Fig. 1](#fig1){ref-type="fig"} B. Because FRET was most clearly observed as an increase in an emission peak of YFP at 527 nm and a decrease in an emission peak of CFP at 475 nm, the emission ratio of YFP/CFP is used to demonstrate the FRET efficiency hereafter.

![**Basic profile of Raichu-RhoA.** (A) Schematic representations of Raichu-RhoA bound to GDP or GTP. YFP and CFP denote a yellow- and cyan-emitting mutant of GFP, respectively. RBD indicates the RBD of the effector protein. (B) Emission spectra of Raichu-RhoA expressed in 293T cells at an excitation wavelength of 433 nm (left). WT, wild type; Q63L, GTPase-deficient mutant; T19N, a mutant with reduced affinity to guanine nucleotides. In the sample treated with protease, Raichu--RhoA--WT was cleaved with trypsin and proteinase K before analysis. (C) 293T cells expressing Raichu-RhoA and Flag-tagged RhoA were labeled with ^32^P*~i~*. The guanine nucleotides bound to the GTPases were analyzed by TLC, and the average of two samples is shown with error bars. Asterisks indicate that the level of guanine nucleotides was beneath the detectable level. (D) pRaichu-RhoA was cotransfected into 293T cells with varying quantities of expression vectors for p115 RhoGEF and Grit. The emission ratio and GTP level were quantitated as in B and C. The emission intensities of CFP at 475 nm and YFP at 527 nm were used to calculate the emission ratio, YFP/CFP. Bars indicate error ranges. Experiments were repeated at least twice and representative data are shown.](200212049f1){#fig1}

To search for the RhoA effector most suitable for the probe, we prepared a pair of probes carrying either the wild-type or Q63L GTPase-deficient mutant of RhoA for each RhoA effector. Wild-type probes with the effector domain of mDia, Rhotekin, and Rhophilin were found to contain extremely high levels of GTP. Consequently, the FRET efficiency was not markedly different between the wild-type and Q63L mutants of these probes ([Table I](#tbl1){ref-type="table"}). We speculate that the RBDs of these proteins inhibit GAPs, and that the resulting high basal GTP levels mask the GTP-dependent increase in FRET efficiency of these probes.

###### Summary of the probes for RhoA activity

  Plasmids[a](#tfn1){ref-type="table-fn"}(WT/QL)   RhoA and effectors[b](#tfn2){ref-type="table-fn"}   Emission ratio[c](#tfn3){ref-type="table-fn"}   GTP                                             
  ------------------------------------------------ --------------------------------------------------- ----------------------------------------------- ----- ---- ------------------------------------ ------------------------------------
                                                   NH~2~ term                                          COOH term                                       WT    QL   Gain                                 WT
                                                                                                                                                                  (%)[d](#tfn4){ref-type="table-fn"}   (%)[e](#tfn5){ref-type="table-fn"}

Numbers of Raichu probes are shown. WT, wild-type RhoA; QL, RhoA with the Gln^63^Leu mutation.

The order of RhoA and the effectors from the NH~2~ terminus to the COOH terminus are shown. For illustration, see [Fig. 1](#fig1){ref-type="fig"}.

Probes were expressed in 293T cells and analyzed with a fluorescent spectrometer as described in the text. Emission intensities of YFP at 527 nm and CPF at 475 nm were used to calculate the emission ratio.

\[(emission ratio of QL mutant) − (emission ratio of WT)\]/(emission ratio of WT).

Probes were expressed in 293T cells, labeled with ^32^P~i~, and analyzed with TLC as described in the text. GTP/(GTP + GDP) is shown as a percentage.

Only in the probe pairs using PKN as the effector, the FRET efficiency of the Q63L mutant was markedly higher than that of the wild-type probe ([Table I](#tbl1){ref-type="table"}). Because the gain was larger in the pair of Raichu--RhoA--1237X and --1238X, we characterized this set of probes further in the following analysis. As a negative control to Raichu--RhoA--1237X, we generated Raichu--RhoA--1239X, in which Asn was substituted for Thr^19^ of RhoA to reduce the affinity to guanine nucleotides. As shown in [Fig. 1](#fig1){ref-type="fig"} B, the FRET efficiency of Raichu--RhoA--1237X (WT) was between those of Raichu--RhoA--1238X (Q63L) and Raichu--RhoA--1239X (T19N). Occurrence of FRET was confirmed by treating cell lysates with trypsin and proteinase K as described previously ([@bib27]). The GTP ratio on Raichu--RhoA--1237X (WT) was 33%, whereas that on Flag--RhoA--WT was 8% ([Fig. 1](#fig1){ref-type="fig"} C). The difference between Raichu--RhoA--1237X (WT) and Flag--RhoA--WT probably reflected the mild inhibition of GAP by the RBD of PKN. The GTP ratio on Raichu--RhoA--1238X (Q63L) and on Flag--RhoA--Q63L were 98 and 95%, respectively. In T19N mutants, binding of guanine nucleotides was not detectable as expected ([@bib8]). Because the FRET efficiency of Raichu--RhoA--1239X (T19N) was significantly lower than that of Raichu--RhoA--1237X (WT), the FRET efficiency of the nucleotide-free form must be lower than that of the GDP-bound form.

Correlation of FRET efficiency with GTP-loading
-----------------------------------------------

To further examine the correlation between GTP loading on Raichu--RhoA--1237X (WT) and the FRET efficiency, dose-responsive curves were obtained with cells expressing various quantities of p115 RhoGEF or Grit, a GAP for Rho-family GTPases ([@bib32]). As shown in [Fig. 1](#fig1){ref-type="fig"} D, both GTP loading and the emission ratio (YFP/CFP) increased by the expression of p115 RhoGEF and decreased by the expression of Grit, and both these effects were dose-dependent. These data demonstrated clearly that Raichu--RhoA--1237X (WT) was regulated by both GEFs and GAPs and validated its use in the monitoring of the balance between GEF and GAP activities for RhoA. Because the prototype Raichu--RhoA--1237X (WT) carries the carboxy-terminal region of Ki-Ras4B at its carboxy terminus, we call this probe Raichu--RhoA/K-Ras--CT hereafter. Also, we constructed a probe with the carboxy terminus of RhoA and named it Raichu--RhoA/RhoA--CT. We did not find any remarkable differences in the response to GEFs or GAPs between the two probes (unpublished data).

Development of Raichu-RBD
-------------------------

In addition to GEFs and GAPs, most Rho-family GTPases are regulated by another class of proteins, RhoGDI. To assess the activity of RhoGDI by monitoring the level of endogenous GTP-RhoA, we prepared another type of probe consisting of an RBD of effectors sandwiched by YFP and CFP ([Fig. 2](#fig2){ref-type="fig"} A). We expected that the binding of endogenous GTP-RhoA to RBD in the probe displaced YFP and CFP, thereby decreasing the FRET efficiency. Again, we tested RBDs of mDia, Rhotekin, Rhophilin, and PKN for the optimization. We also tested several monomeric mutants of YFP and CFP ([@bib46]) to improve the sensitivities of the probes. For the sake of simplicity, we will limit ourselves to a description of the best probe derived from the many trials, Raichu-1502 (hereafter used as Raichu-RBD), which consisted of monomeric YFP-L^222^K/F^224^R, the RBD of Rhotekin, and CFP. As shown in [Fig. 2](#fig2){ref-type="fig"} B, the FRET efficiency of Raichu-RBD was decreased in the presence of wild-type RhoA or constitutively active RhoA, but not in the presence of dominant-negative RhoA, indicating that the decrease in FRET correlated with the binding to RhoA. Surprisingly, wild-type RhoA decreased FRET of the probe as efficiently as did the constitutively active RhoA. This may be explained by the property of Raichu-RBD that the FRET efficiency of Raichu-RBD--expressing cells correlated with the net amount of GTP-RhoA, but not with the GTP/GDP ratio on RhoA. In the overexpression system, the wild-type RhoA might provide a saturating amount of GTP-RhoA. Furthermore, we also examined the spectrogram of Raichu-RBD in living HeLa cells by using a flat field imaging spectrograph and obtained a similar result ([Fig. 2](#fig2){ref-type="fig"} C). The difference in the emission ratio between [Fig. 2](#fig2){ref-type="fig"} B and [Fig. 2](#fig2){ref-type="fig"} C arose mostly from the difference in the filter sets used to dissect the fluorescences of YFP and CFP. These observations supported the idea that the FRET efficiency of Raichu-RBD reflected its binding to the endogenous RhoA. We also prepared a probe named Raichu--RBD--X, wherein carboxy terminus of RhoA was fused to Raichu-RBD. By placing the probe only to the membrane, we could reduce the background from the probe in the cytoplasm.

![**Basic profile of Raichu-RBD.** (A) Schematic representations of Raichu-RBD unbound or bound to GTP-RhoA. RBD indicates the RBD of Rhotekin. (B) Cleared lysates of Raichu-RhoA--expressing 293T cells were used to obtain spectrograms at an excitation wavelength of 433 nm. The emission intensities of CFP at 475 nm and YFP at 527 nm were used to calculate the emission ratio, YFP/CFP (*n* = 3). Bars indicate SD. (C) Spectrograms of Raichu-RBD with or without Rho proteins were obtained in living HeLa cells. The emission intensities of CFP at 475 nm and YFP at 530 nm were used to calculate the emission ratio, YFP/CFP (*n* = 5). Bars indicate SD.](200212049f2){#fig2}

Imaging of the activities of Rho-family GTPases in living cells
---------------------------------------------------------------

Before FRET imaging, the intracellular localizations of the probes were compared with those of the Rho-family GTPases tagged with GFP ([Fig. 3](#fig3){ref-type="fig"} A). The distribution of GFP-tagged Rho-family GTPases was in general agreement with the previous report ([@bib22]); GFP--RhoA--WT was observed mostly in the cytoplasm, and GFP--Rac1--WT and GFP--Cdc42--WT were observed at both the plasma membrane and intracellular membrane compartments. The active forms of GFP-tagged Rho-family GTPases were detected both at the plasma membrane and the intracellular membrane compartments. The distribution of Raichu--RhoA/RhoA--CT, Raichu--Rac1/Rac1--CT, and Raichu--Cdc42/Cdc42--CT was indistinguishable from those of the constitutively active mutants, supporting the previous finding that the carboxy-terminal region primarily determines the localization of the Rho-family GTPases in their active forms ([@bib22]; [Fig. 3](#fig3){ref-type="fig"} A, third column). In a clear contrast, all probes with the carboxy terminus of K-Ras4B were localized mainly at the plasma membrane ([Fig. 3](#fig3){ref-type="fig"} A, fourth column). The distribution of Raichu-RBD was typical for a cytosolic protein ([Fig. 3](#fig3){ref-type="fig"} A, bottom).

![**Localization and FRET imaging of Raichu probes.** (A) HeLa cells expressing GFP-tagged Rho-family GTPases of the wild-type (WT) or constitutively active form (Active) are presented in the first two columns. The next two columns show HeLa cells expressing Raichu probes with either the authentic carboxy termini (CT) or K-Ras4B CT. A cell image of Raichu-RBD--expressing cells is also shown at the bottom of A. Cells were excited by an Argon laser at a 488-nm wavelength and imaged with a confocal microscope. (B) Ratio imaging by TPEM. HeLa cells expressing the Raichu probes listed on the left were imaged for YFP (535 ± 12 nm) and CFP (480 ± 15 nm) with a 790-nm excitation wavelength. XY planes from the bottom to the top of each cell were stacked, and the YFP/CFP ratio image is used to show the FRET efficiency in the intensity-modulated display mode. XZ sections were prepared along the dotted white lines. White bars indicate 10 μm (A and B). The upper and lower limits of the ratio range are shown at the right of each panel.](200212049f3){#fig3}

Using these Raichu probes and two-photon excitation fluorescence microscopy (TPEM), which enabled us to minimize photobleaching during z-axis scanning and to increase signal-to-noise ratio, the activities of Rho-family GTPases were imaged in HeLa cells ([@bib7]). Cells expressing Raichu probes were imaged for YFP (535 ± 12 nm) and CFP (480 ± 15 nm) with an excitation wavelength of 790 nm ([Fig. 3](#fig3){ref-type="fig"} B). The YFP/CFP ratio image is used to show the FRET efficiency in the intensity-modulated display mode. A high FRET ratio of Raichu--RhoA/RhoA--CT was observed mostly at the plasma membrane. Very similar results were also obtained by using Raichu--Rac1/Rac1--CT and Raichu--Cdc42/Cdc42--CT. Thus, we concluded that the GEF/GAP balances of RhoA, Rac1, and Cdc42 were higher at the plasma membrane than at the intracellular membrane compartments in the interphase. Essentially the same conclusion was obtained by using the Raichu-RBD probe. Notably, binding of Raichu-RBD to the endogenous Rho decreases FRET efficiency ([Fig. 2](#fig2){ref-type="fig"}); therefore, in contrast to the other probes, the low FRET efficiency at the plasma membrane indicates a high level of GTP-Rho in this area. These observations are in agreement with the previous finding that RhoA, Rac, and Cdc42 are predominantly translocated to the plasma membrane by the expression of GEF or integrin stimulation ([@bib6]; [@bib22]; [@bib3]). It should be emphasized that the presence of FRET probes at the intracellular membrane compartments hinders the detection of activity change at the plasma membrane when we use a conventional epifluorescence microscope. This is because we cannot eliminate signals from the intracellular membrane compartments without the use of a two-photon excitation microscope or a confocal microscope. Therefore, the Raichu probes with a K-Ras4B carboxy-terminal region, which were localized mostly at the plasma membrane ([Fig. 3](#fig3){ref-type="fig"} B), were superior to the Raichu probes with the authentic carboxy termini in terms of the sensitivity in detecting the activity change at the plasma membrane. Hence, in many of the following experiments, we used Raichu--RhoA/K-Ras--CT because most of the activity change during cytokinesis was observed at the plasma membrane by TPEM. The occurrence of FRET in the cells was also confirmed by the previously reported photobleaching experiments ([@bib24]); The FRET efficiencies were calculated as 29 ± 4.7% for Raichu--RhoA/K-Ras--CT and 46 ± 1.5% for Raichu-RBD.

Next, we tested if Raichu-RhoA could monitor the activity change of RhoA in the conditions where RhoA is known to be activated or inactivated. First, we observed diffuse increase in FRET efficiency in N1E-115 neuroblastoma cells expressing Raichu-RhoA and stimulated with lysophosphatidic acid (Fig. S1, available at <http://www.jcb.org/cgi/content/full/jcb.200212049/DC1>; [@bib29]). Second, nocodazole treatment of HeLa cells expressing Raichu--RhoA/K-Ras--CT increased in FRET efficiency (Fig. S1; [@bib21]). Third, when cells expressing Raichu--RhoA/K-Ras--CT were treated with a RhoA inhibitor C3, FRET efficiency decreased (Fig. S2). In these experiments, the change in FRET efficiency correlated very well with the change in the level of endogenous GTP-RhoA as examined by the pull-down analysis.

Furthermore, to evaluate the effect of expression of Raichu-RhoA on the endogenous RhoA signaling cascade, we examined actin stress fiber formation (Fig. S3). We could not detect any difference in the formation of actin stress fiber between the nontransfected and transfected cells (Fig. S3), indicating that the expression of Raichu-RhoA did not perturb the RhoA signaling to a detectable level. Similarly, we could not detect any anomaly in cell shape, migration, or division by a modest expression of the probes.

Activity of Rho-family GTPases in HeLa cells progressing from G2 to G1 phase
----------------------------------------------------------------------------

Using these Raichu probes, we examined the activity of RhoA, Rac1, and Cdc42 in living HeLa cells progressing from G2 to G1 phase ([Fig. 4](#fig4){ref-type="fig"} A; Videos 1--3). In this experiment, the objective lens was focused on the basal plasma membrane before imaging, and was fixed during the experiment. For this and the aforementioned reasons, we show here the results obtained by using the probes with K-Ras4B carboxy-terminal region, although we obtained essentially the same results with probes with the authentic carboxy-terminal regions. To show the time course of activity change more quantitatively, we calculated the emission ratios from the averaged intensities of YFP and CFP and plotted them against the cell cycle stage ([Fig. 4](#fig4){ref-type="fig"} B). On entry into prophase, the level of RhoA activity decreased rapidly, leaving high activity at the periphery of the cells. After reaching its nadir at anaphase, the RhoA activity increased gradually in telophase. Essentially the same result was obtained by using Raichu-RhoA and Raichu-RBD. The activity of Rac1 decreased on the entry into prometaphase and reached its lowest level at early telophase, later than RhoA. After the midbody formation, Rac1 activity increased rapidly in the late telophase. Cdc42 activity changed essentially as did Rac1 activity, although the level of activity change was less remarkable. When we used Raichu--Cdc42/Cdc42--CT, we sometimes observed transient and moderate increase in Cdc42 activity in anaphase; however, we could not appreciate its significance at this moment. No detectable change in the FRET efficiency was observed in Raichu--Pak--Rho-expressing cells. We have obtained at least six similar video images of cell division for each probe.

![**Activities of Rho-family GTPases in HeLa cells progressing from G2 to G1 phase.** (A) HeLa cells were infected with recombinant adenoviruses for the expression of Raichu--RhoA/K-Ras--CT, Raichu--Rac1/K-Ras--CT, and Raichu--Cdc42/K-Ras--CT as indicated at left. Raichu--Pak--Rho and Raichu--RBD--X was introduced by lipofection. CFP, YFP, and differential interference contrast images were obtained every 2 min with a time-lapse epifluorescent microscope. A ratio image of YFP/CFP was used to represent FRET efficiency. The stages of cell cycle were determined by the differential interference contrast images. Representative FRET images are shown at each stage of the cell cycle denoted at the top of the figure. The upper and lower limits of the ratio range are shown at the right of each panel. At least six similar images were obtained for each probe, and a representative one is used here. White bars indicate 10 μm. (B) From the images in A, the net intensities of YFP and CFP in each cell were measured to calculate the averaged emission ratio.](200212049f4){#fig4}

Activity change of Rho-family GTPases during cytokinesis
--------------------------------------------------------

Because the most drastic activity changes occurred after metaphase, we concentrated our efforts on the period from anaphase to telophase and performed experiments by continuously focusing at the middle depth of the cells ([Fig. 5](#fig5){ref-type="fig"}). In early telophase, the RhoA activity gradually increased at the plasma membrane, including the cleavage furrow. This increase was less pronounced when we used Raichu--RhoA/RhoA--CT ([Fig. 5](#fig5){ref-type="fig"} A), but was more clear by using Raichu--RhoA/K-Ras4B--CT ([Fig. 5](#fig5){ref-type="fig"} C) or by TPEM ([Fig. 5](#fig5){ref-type="fig"} D). The increase in RhoA activity at the plasma membrane was confirmed by using Raichu-RBD ([Fig. 5](#fig5){ref-type="fig"} B). In contrast to RhoA, the activity of Rac1 was suppressed at the center and started increasing from the polar sides of the plasma membrane at late telophase after the abscission of daughter cells ([Fig. 5, A and C](#fig5){ref-type="fig"}). Suppression of Rac1 activity at the cleavage furrow was more clearly depicted by TPEM ([Fig. 5](#fig5){ref-type="fig"} D). The activity of Cdc42 was high at the intracellular membrane compartments and did not change remarkably from anaphase to telophase; however, we noticed that the activity always reached its nadir at the time of abscission of daughter cells ([Fig. 5](#fig5){ref-type="fig"} A).

![**Activity of Rho-family GTPases during cytokinesis.** HeLa cells expressing Raichu probes with carboxy termini of the authentic proteins (A) or Ki-Ras4B (C) or expressing Raichu-RBD (B) were photographed as in [Fig. 4](#fig4){ref-type="fig"} A, except that the fluorescent images were focused at the middle depth of the cells and subjected to median filtering to reduce noise. The elapsed time is denoted at the top of the figure. The time zero is set to metaphase. At least six similar images were obtained for each probe, and a representative one is shown here. White bars indicate 10 μm. (D) HeLa cells expressing Raichu probes were imaged at early telophase by TPEM as in [Fig. 3](#fig3){ref-type="fig"} B. Horizontal (X-Y) and vertical (X-Z) sections are shown.](200212049f5){#fig5}

To examine if the activity change correlated with the accumulation of the Rho-family GTPases, localizations of GFP-tagged RhoA, Rac1, and Cdc42 were determined with a confocal microscope (Fig. S4). GFP-RhoA localized mostly in the cytoplasm, GFP-Rac1 both at the plasma membrane and cytoplasm, and GFP-Cdc42 at the intracellular membrane compartments. However, against our expectation, we did not observe remarkable change in the distribution of RhoA, Rac1, or Cdc42 during cytokinesis. RhoGDI may not contribute to the regulation of Rho-family GTPases during cytokinesis to a detectable level.

Discussion
==========

It has been well documented that Rho-family GTPases are required for cytokinesis of many cell types ([@bib39]). Because stress fibers and focal contacts disassemble during cell division, it is predicted that Rho is deactivated as cells enter mitosis and is reactivated during cytokinesis ([@bib37]). However, to the best of our knowledge, only two papers have examined Rho activity in relation to cell division ([@bib14]; [@bib21]). Both groups have analyzed the level of GTP-RhoA by Bos\' pull-down method in HeLa cells arrested at metaphase with nocodazole or taxol; however, the results are significantly different. [@bib14] claim that RhoA activity remains low in G1 to S phase and increases remarkably at telophase. In contrast, [@bib21] propose that RhoA activity increases at metaphase. Our observations agreed with Kimura\'s report ([@bib14]) in that RhoA activity started increasing after metaphase in HeLa cells, but disagreed with both reports in that the significant decrease in RhoA activity was found at the G2/M transition in our work. The discrepancy between the previous papers and ours may have arisen from the procedure to collect the mitotic cells before the pull-down analysis. On the other hand, we focused on the bottom of the cells during mitosis; therefore, on entry into M phase, the net intensities of both YFP and CFP were decreased by the rounding of the cells. It is possible that the observed activity change may be biased to the plasma membrane of the bottom of the cells.

It has been hypothesized that RhoA is specifically activated at the cleavage furrow during cytokinesis. The most supportive evidence for this hypothesis is that RhoA is recruited to the cleavage furrow in Swiss3T3 cells and sea urchin eggs ([@bib43]; [@bib35]). Further support comes from the findings that three Rho effectors, ROCK ([@bib45]; [@bib16]), mDia ([@bib2]; [@bib44]), and citron ([@bib20]) are recruited to the cleavage furrow. However, analyses using adherent cells have challenged this hypothesis, proposing that cytokinesis can take place through an "attachment-assisted mitotic cleavage" mechanism ([@bib34]; [@bib41]; [@bib37]). In this model, the decrease in RhoA activity causes cortical disintegration and cytokinesis in adherent cells ([@bib37]). We support this model based on the following observations from the present work. First, RhoA activity decreased on entry into mitosis. Second, RhoA activity was not particularly concentrated at the cleavage furrow. Lastly, we barely detected an increase in RhoA activity at the plasma membrane of Rat1A cells before abscission of the daughter cells (unpublished data). Of note, we confirmed that GFP-citron was condensed at the cleavage furrow in HeLa cells (unpublished data). Thus, citron, and possibly other RhoA effectors involved in cytokinesis, may be accumulated at the cleavage furrow with the help of other unknown mechanisms.

Previous papers have shown that Rac and Cdc42 are involved in the cytokinesis of mammalian cells, based on the appearance of multinucleated cells in cells expressing constitutively active Rac1 or Cdc42 ([@bib5]; [@bib30]). Our observation that the activity of Rac1 and Cdc42 decreased during cytokinesis agrees with these previous reports and also with the finding that MgcRacGAP, a Rac GAP, accumulates at the mitotic spindle and midbody during cell division ([@bib12]). This suppression of Rac1 and Cdc42 may play a role in cytokinesis via Pak, an effector of Rac1 and Cdc42; Pak negatively regulates myosin light chain kinase, which phosphorylates and activates myosin II to induce actomyosin-based contraction ([@bib40]). Thus, suppression of Rac1 and Cdc42 may eventually promote constriction of actomyosin at the cleavage furrow.

After the construction of several trial probes, it has become clear that the affinity of the effector to GTPases should be moderate in order to develop a Raichu-RhoA probe with a wide dynamic range. Among the four effector proteins tested, only PKN yielded a probe that could be used for cell imaging. The GTP ratio on the probes with the effectors other than PKN were nearly (or greater than) 80%, indicating that these probes were refractory to GAPs. Because the GTP level on these probes did not significantly change by the orientation of effectors and RhoA, the linker regions used in Raichu probes seem to allow the effectors to fit flexibly into RhoA. For the same reason, it is also unlikely that steric confinement reduced the intrinsic GTPase activity of RhoA in these probes. Thus, we conclude that the high GTP levels on the probes reflect the high affinity of the effectors to RhoA. We observed a similar decrease in GAP sensitivity during the development of Raichu-Rap1 ([@bib27]). We originally constructed the Raichu-Rap1 probe with the Rap1-binding domain of RalGDS. In this probe, the GTP ratio on Raichu-Rap1 was \>60%, whereas that on Flag-Rap1 was \<5% in 293T cells (unpublished data). Only by replacing RalGDS with Raf was the GTP level on Raichu-Rap1 reduced to \<25%. Notably, the affinity of Rap1 to RalGDS is remarkably higher than that to Raf ([@bib11]). Thus, in order to develop probes for low mol wt GTPases, it is essential to search for a target molecule that possesses moderate affinity to the GTPases in order to minimize the inhibitory effect on GAP. Alternatively, we could introduce mutation into the effector-binding region of RhoA or the RhoA-binding region of the effector to reduce the affinity.

The finding that the GTP ratio on Raichu-RhoA was higher than that on the authentic RhoA may raise a question about the extent to which this probe reflects the activity change of GAPs. Because some GAPs prefer prenylated RhoA as their substrate ([@bib28]), intervention of CFP between RhoA and the prenylation signal at the carboxyl terminus may decrease the sensitivity of Raichu-RhoA to such GAPs. This problem is not limited to GAPs or prenylation. We cannot exclude the possibility that some Rho GEFs or Rho GAPs may not recognize Raichu-RhoA. In this regard, use of Raichu-RBD, which works on a different mechanism, will help to confirm the observation obtained by Raichu-RhoA.

In conclusion, we have shown the spatio-temporal regulation of Rho-family GTPases during cell division by two types of Raichu probes. One is able to monitor the local balance between GEFs and GAPs, and the other is able to depict the presence of GTP-Rho, enabling us to assess the contribution of all three regulators of Rho-family GTPases. Because none of the other existing methods can obtain spatio-temporal information on the activities of Rho-family GTPases in living cells, these Raichu probes will provide a versatile tool for exploring the role of these proteins in many research fields.

Materials and methods
=====================

Plasmids
--------

pRaichu-Ras, pRaichu-Rac1, and pRaichu-Cdc42 have been described previously ([@bib27]; [@bib13]). Because the prototype Raichu-Rac1 and Raichu-Cdc42 are fused to the carboxy-terminal region of Ki-Ras4B, we call these Raichu--Rac1/K-Ras--CT and Raichu--Cdc42/K-Ras--CT, respectively. Raichu--Rac1/Rac1--CT and Raichu--Cdc42/ Cdc42--CT were fused to the carboxy-terminal region of Rac1 (aa 172--192) and Cdc42 (aa 171--191), respectively. cDNA of Rhotekin was PCR amplified from a mouse spleen cDNA library (CLONTECH Laboratories, Inc.). cDNAs of mDia and Rhophilin were provided by S. Narumiya (Kyoto University, Kyoto, Japan). cDNA of PKN was obtained from Y. Ono (Kobe University, Kobe, Japan). An expression vector of p115 RhoGEF was obtained from T. Kozasa (University of Illinois, Chicago, IL). pCI-GritCD has been described previously ([@bib32]). The coding region of human RhoA was subcloned into two eukaryotic expression vectors, pCXN2-Flag ([@bib36]) and pCAGGS-EGFP, to generate pCXN2--Flag--RhoA and pCAGGS--EGFP--RhoA, respectively.

Construction of Raichu probes for RhoA activity
-----------------------------------------------

cDNAs of the RBDs of effector proteins, including human mDia1 (aa 1--176), mouse Rhotekin (aa 1--88), mouse Rhophilin (aa 37--107), human PKN (aa 13--98), and a cDNA of the Rac1/Cdc42-binding domain of PAK (aa 68--150) were PCR amplified with primers carrying restriction enzyme recognition sites at their 5′ end, and subcloned into pCR^®^-Blunt II-TOPO^®^ (Invitrogen). Plasmids for RhoA monitors were constructed using essentially the same procedure as was used to construct pRaichu-Ras ([@bib27]). From the amino terminus, Raichu--RhoA--1202, --1208, --1125, --1126, --1206, and --1212 consisted of YFP (aa 1--228), a spacer (Leu-Asp), wild-type or mutants of human RhoA (aa 1--189), a spacer (Thr-Gly-Gly-Gly-Gly-Thr), the RBD of effector proteins, a spacer (Gly-Gly-Arg), and CFP (aa 1--237). Raichu-1110X, -1111X, -1214X, -1220X, -1104X, -1105X, -1218X, and -1224X consisted of YFP (aa 1--228), a spacer (Leu-Asp), the RBD of effector proteins, a spacer (Thr-Gly-Gly-Gly-Gly-Thr), human RhoA (aa 1--189), a spacer (Gly-Gly-Arg), CFP (aa 1--237), a spacer (Ser-Arg), and the carboxy-terminal region of Ki-Ras4B (aa 169--188). Raichu--RhoA--1237X, --1238X, and --1239X consisted of YFP (aa 1--228), a spacer (Leu-Asp), the RBD of PKN, a spacer (Thr-Gly-Gly-Gly-Thr-Gly-Gly-Gly-Gly-Thr), wild-type or mutants of human RhoA (aa 1--189), a spacer (Gly-Gly-Arg), CFP (aa 1--237), a spacer (Gly-Arg-Ser-Arg), and the CAAX box of Ki-Ras4B (aa 169--188; [Fig. 1](#fig1){ref-type="fig"} A). In Raichu--RhoA/RhoA--CT, the carboxy-terminal region of RhoA (aa 173--193) was substituted for that of Ki-Ras4B in Raichu--RhoA--1237X.

The effector proteins used in each probe are listed in [Table I](#tbl1){ref-type="table"}. In Raichu--RhoA--1239X, Asn was substituted for Thr^19^ of RhoA. In the other probes, RhoA was either the wild-type or Gln^63^Leu mutant (Q63L), as denoted in [Table I](#tbl1){ref-type="table"}. In this paper, unless indicated otherwise, we used modified YFP \[Thr^66^Gly, Val^69^Leu, Ser^73^Ala, Met^154^Thr, Val^164^Ala, Ser^176^Gly, and Thr^204^Tyr\] and CFP \[Lys^27^Arg, Tyr^67^Trp, Asp^130^Gly, Asn^147^Iso, Met^154^Thr, Val^164^Ala, Asn^165^His, Ser^176^Gly\] as the acceptor and the donor, respectively. The nucleotide sequence of the coding regions of pRaichu--RhoA--1237X, which was used as a Raichu--RhoA/K-Ras--CT in this report, was deposited in the GenBank/EMBL/DDBJ databank (under accession no. [AB074297](AB074297)).

Raichu--1502/Raichu--RBD consisted of YFP (aa 1--228), a spacer (Leu-Glu), the RBD of Rhotekin (aa 1--88), a spacer (Gly-Gly-Arg), and CFP (aa 1--237). In Raichu--1502/Raichu--RBD, a monomeric Venus \[Phe^47^Leu, Thr^66^Gly, Val^69^Leu, Ser^73^Ala, Met^154^Thr, Val^164^Ala, Ser^176^Gly; and Thr^204^Tyr, Leu^222^Lys, Phe^224^Arg\] ([@bib31]; [@bib46]) was used as a YFP. In Raichu--Raichu--RBD--X, the carboxy-terminal region of RhoA was fused to Raichu-RBD.

Adenovirus vectors
------------------

A recombinant adenovirus for the expression of Raichu-RhoA was prepared by using the Adeno-X expression system (CLONTECH Laboratories, Inc.). In brief, the coding region of pRaichu--RhoA--1237X was first subcloned into pShuttle. Then, the expression unit including the cDNA of Raichu-RhoA was transferred to pAdeno-X by restriction enzyme cleavage and ligation. Finally, the adenovirus was produced from 293 cells transfected with the recombinant pAdeno-X. Recombinant adenoviruses carrying Raichu-RhoA were designated as Adeno--Raichu--RhoA. Preparation of the other recombinant adenoviruses was as described elsewhere ([@bib13]). Adeno--GFP--C3 was a gift from H. Kurose (Kyusyu University, Fukuoka, Japan).

Cells
-----

HEK293 and HeLa cells were purchased from the Human Science Research Resources Bank (Sennan-shi, Japan). 293T and Swiss 3T3 cells were a gift from B.J. Mayer (University of Connecticut, Storrs, CT) and S. Narumiya (Kyoto University, Kyoto, Japan), respectively. Cells were maintained in DME (Sigma-Aldrich) supplemented with 10% FBS. Before the cell imaging, the medium was changed to phenol red--free MEM (Nissui).

In vitro spectrofluorometry
---------------------------

pRaichu plasmids were transfected into 293T cells by the calcium phosphate coprecipitation method with or without various quantities of plasmids for p115 Rho GEF, Grit-CD, or RhoA as described previously ([@bib27]). 36 h later, cells were harvested in lysis buffer (20 mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.5% Triton X-100, and 5 mM MgCl~2~) and clarified by centrifugation. Fluorescence spectra were obtained with a fluorescent spectrometer (model FP-750; JASCO Co.) using an excitation wavelength of 433 nm. For the demonstration of FRET, the cell lysates were incubated with 12.5 μg/ml trypsin and 50 μg/ml proteinase K at 37°C for 10 min and analyzed with the spectrometer.

Imaging spectrofluorometry
--------------------------

Plasmids encoding Raichu probes were transfected into HeLa cells using SuperFect^®^ (QIAGEN) with or without plasmids for RhoA wild-type or mutants. 36 h later, cells were imaged on an inverted microscope (model IX71; Olympus) that was equipped with a flat field imaging spectrograph (SpectraPro 150; Acton Research Co.), a cooled CCD camera (Spec-10:256E; Roper Scientific), and WinSpec32 software (Roper Scientific). Cells were observed with a 75-W Xenon lamp with a 12% ND filter (Olympus), an excitation filter (MX0420; Asahi Spectra Co.), a dichroic mirror (445DRLP; Omega Optical Inc.), and an oil immersion objective lens (60× Plan Apo; Olympus).

Analysis of guanine nucleotides bound to GTPases
------------------------------------------------

Guanine nucleotides bound to Raichu probes and Flag-RhoA were analyzed essentially as described previously ([@bib9]). In brief, 293T cells were transfected with pRaichu-RhoA or pCXN2--Flag--RhoA. 36 h after transfection, cells were labeled with ^32^P*~i~* in phosphate-free modified Eagle\'s medium (Invitrogen) for 4 h. Raichu-RhoA and Flag-RhoA were immunoprecipitated with anti-GFP antibody prepared in the Matsuda laboratory and anti-Flag M2 mAb (Sigma-Aldrich), respectively. The immunoprecipitates were boiled and analyzed by TLC. The amount of GTP and GDP bound to RhoA was quantitated with an image analyzer (BAS-1000; Fuji Film).

Imaging of RhoA activity in living cells
----------------------------------------

HeLa cells transfected with pRaichu-derived vectors or infected with recombinant adenoviruses were imaged every 2 min on an inverted microscope (model IX70; Olympus) that was equipped with a cooled CCD camera (CoolSNAP HQ™; Roper Scientific), and controlled by MetaMorph^®^ software (Universal Imaging Corp.; [@bib25]). For dual-emission ratio imaging of Raichu probes, we used a 440AF21 excitation filter, a 455DRLP dichroic mirror, and two emission filters; 480AF30 for CFP and 535AF26 for YFP (all filters and mirrors from Omega Optical, Inc.). Cells were illuminated with a 75-W Xenon lamp through a 12% ND filter (Olympus) and a 100× oil immersion objective lens. The exposure time was 0.5 s when the binning of the CCD camera was set to 4 × 4. After background subtraction, the ratio image of YFP/CFP was created with MetaMorph^®^ software and used to represent FRET efficiency. For the photobleaching experiment, Raichu-RhoA--expressing cells were illuminated without an ND filter for 5 min. In this experiment, we used an excitation filter (MX510; Asahi Spectra Co.) and a dichroic mirror (XF2052; Omega Optical, Inc.). FRET efficiency was calculated by the following equation: FRET efficiency = 1 − (CFP prebleach/CFP postbleach).

Confocal microscopy and TPEM
----------------------------

Cells were observed with a multi-photon excitation microscope (model FV500; Olympus) equipped with external photomultiplier tubes, an Argon laser, an He:Ne laser, and a MAITAI Ti:sapphire laser (Spectra Physics). The MAITAI laser was capable of generating a \>100-fs pulse at a repetition rate of 80 MHz. The output wavelength was tunable from 780 to 920 nm. The output laser beam, with a power \>0.7 W, was horizontally polarized. The excitation wavelength for the TPEM was 790 nm as described previously ([@bib7]). For the FRET imaging, we used an IR-cut filter (RDM650; Olympus), a dichroic mirror (DM505; Olympus), and two emission filters; 480AF30 for CFP and 535AF26 for YFP (Omega Optical, Inc.). For the conventional confocal imaging with the Argon laser, we used two dichroic mirrors, DM458/515 and SDM 515; and emission filters, BA480--495 for CFP and BA535--565 for YFP (Olympus).

Online supplemental material
----------------------------

Time-lapse FRET images of [Fig. 4](#fig4){ref-type="fig"} are compiled into QuickTime videos available as supplemental material. Videos 1--3 show the cell division of HeLa cells expressing Raichu--RhoA/K-Ras--CT, Raichu--Rac1/K-Ras--CT, and Raichu--Cdc42/K-Ras--CT, respectively. Differential interference contrast, CFP, and YFP images were acquired every 2 min overnight, and frames spanning cell division were used to create video files. FRET images are shown in the IMD mode. The video is displayed at 15 frames/s. Fig. S1 to Fig. S4 show basic properties of Raichu probes. Online supplemental material available at <http://www.jcb.org/cgi/content/full/jcb.200212049/DC1>.

Supplemental Material
=====================
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